AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.06 Decreased By ▼ -0.47 (-0.36%)
BOP 6.75 Increased By ▲ 0.07 (1.05%)
CNERGY 4.49 Decreased By ▼ -0.14 (-3.02%)
DCL 8.55 Decreased By ▼ -0.39 (-4.36%)
DFML 40.82 Decreased By ▼ -0.87 (-2.09%)
DGKC 80.96 Decreased By ▼ -2.81 (-3.35%)
FCCL 32.77 No Change ▼ 0.00 (0%)
FFBL 74.43 Decreased By ▼ -1.04 (-1.38%)
FFL 11.74 Increased By ▲ 0.27 (2.35%)
HUBC 109.58 Decreased By ▼ -0.97 (-0.88%)
HUMNL 13.75 Decreased By ▼ -0.81 (-5.56%)
KEL 5.31 Decreased By ▼ -0.08 (-1.48%)
KOSM 7.72 Decreased By ▼ -0.68 (-8.1%)
MLCF 38.60 Decreased By ▼ -1.19 (-2.99%)
NBP 63.51 Increased By ▲ 3.22 (5.34%)
OGDC 194.69 Decreased By ▼ -4.97 (-2.49%)
PAEL 25.71 Decreased By ▼ -0.94 (-3.53%)
PIBTL 7.39 Decreased By ▼ -0.27 (-3.52%)
PPL 155.45 Decreased By ▼ -2.47 (-1.56%)
PRL 25.79 Decreased By ▼ -0.94 (-3.52%)
PTC 17.50 Decreased By ▼ -0.96 (-5.2%)
SEARL 78.65 Decreased By ▼ -3.79 (-4.6%)
TELE 7.86 Decreased By ▼ -0.45 (-5.42%)
TOMCL 33.73 Decreased By ▼ -0.78 (-2.26%)
TPLP 8.40 Decreased By ▼ -0.66 (-7.28%)
TREET 16.27 Decreased By ▼ -1.20 (-6.87%)
TRG 58.22 Decreased By ▼ -3.10 (-5.06%)
UNITY 27.49 Increased By ▲ 0.06 (0.22%)
WTL 1.39 Increased By ▲ 0.01 (0.72%)
BR100 10,445 Increased By 38.5 (0.37%)
BR30 31,189 Decreased By -523.9 (-1.65%)
KSE100 97,798 Increased By 469.8 (0.48%)
KSE30 30,481 Increased By 288.3 (0.95%)
World

Chinese firm to make 60mn doses of Russia's Sputnik vaccine

  • The Sputnik V vaccine has been registered in 57 countries, with a total population of more than 1.5 billion people.
Published March 29, 2021

MOSCOW: Russia has agreed a deal for more than 60 million doses of its Sputnik V vaccine to be produced in China from May, the jab's developer said on Monday.

The Russian Direct Investment Fund (RDIF), which has financed the development of the vaccine, said it and Shenzhen Yuanxing Gene-tech Co. "have agreed to cooperate on production of over 60 million doses" of Sputnik in China.

The RDIF, Russia's sovereign wealth fund that has backed the development of the vaccine, said that the amount of the two-dose vaccine would be enough to vaccinate some 30 million people, adding that production would begin in May.

"Cooperation with Shenzhen Yuanxing Gene-tech will enable us to produce Sputnik V in China, thus increasing the capacities to provide additional amounts as we see rising demand for the Russian vaccine globally," CEO Kirill Dmitriev said in a statement.

The West has accused Beijing and Moscow of using their vaccines as tools to win geopolitical clout.

Russia and China have rejected claims that they are seeking to use coronavirus vaccines to project their influence and accused Western countries of hoarding vaccines to the detriment of poor nations.

The Sputnik V vaccine has been registered in 57 countries, with a total population of more than 1.5 billion people.

Comments

Comments are closed.